Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Steroid study seeks clues to prevent preemie lung disease

NCT ID NCT01854840

First seen Mar 08, 2026 · Last updated Jun 18, 2026 · Updated 18 times

Summary

This study looked at 127 pregnant women who received a steroid called betamethasone to help prevent lung problems in their premature babies. Researchers measured how much of the drug reached the baby and whether it reduced the risk or severity of hyaline membrane disease, a serious breathing condition. The goal was to better understand the link between drug transfer and newborn lung health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYALINE MEMBRANE DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Necker Hospital

    Paris, 75015, France

Conditions

The condition(s) this trial relates to.

Hyaline Membrane Disease newborn respiratory distress syndrome respiratory distress syndrome in premature infants prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.